Drug Research
Axsome Pitches Auvelity As A Depression Med Game-Changer
It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with...
News
As Vaccine Firms Prep For A Busy Season, Influenza May Hit
Flu season is just around the horizon as the summer draws to a close and fall looms. Influenza still poses a threat, and leading...
Drug Research
Gene Therapy By Bluebird Bio Costing $2.8M Given Nod By FDA
Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in the US.
Zynteglo, sometimes known as betibeglogene autotemcel (beti-cel), was...
Press Releases
Achema 2022: Syntegon presents new Service Agreements
At this year’s Achema, Syntegon will present redesigned Service Agreement packages for effective asset and maintenance management at fixed costs. The varied agreements help...
Drug Research
ADCs Built On Starpharma Delivery Tech To Be Tested By Merck
As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will...
Drug Research
After Roe, Bayer Engages Lobbyists For Contraception Access
While a large portion of the biopharma industry prepares for a battle over medication prices, Bayer is getting ready for a different lobbying push...
Drug Research
Trodelvy Wins A Battle Against Breast Cancer With Gilead
Gilead staked money on Trodelvy providing a life-extension benefit when it failed to show promise in halting tumour development in HR-positive HER2-negative breast cancer....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read